Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
(2019)
Journal Article
Background: Androgen Receptor (AR) has emerged as a potential therapeutic target for AR-positive triple-negative breast cancer (TNBC). However, conflicting reports regarding AR’s prognostic role in TNBC are putting its usefulness in question. Some st... Read More about Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.